Celleration

company

About

Celleration is a medical device company developing and commercializing therapeutic ultrasound platforms.

  • 51 - 100

Details

Last Funding Type
Series D
Last Funding Money Raised
$30M
Industries
Health Care,Medical,Medical Device,Therapeutics
Founded date
Jan 1, 1999
Number Of Employee
51 - 100
Operating Status
Active

Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform.

Celleration’s core product, the MIST Ultrasound Healing Therapy® System delivers low frequency ultrasound through a saline mist. Unlike conventional wound treatments that are limited to treating the surface, MIST Therapy delivers ultrasound energy into and below the wound bed to stimulate cells to positively impact all critical aspects of the wound healing process.

Celleration received 510K clearance from the FDA in 2005 with the full claim of “promote wound healing”. Shortly thereafter, the company introduced the MIST Therapy System to the US market and has since built an impressive body of clinical evidence demonstrating significant clinical and economic benefits in hundreds of facilities across the United States. Currently, over over 1 million MIST® Therapy treatments have been performed in the United States and U.K. benefiting more than 65,000 patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Celleration has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Jul 20, 2008 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 20, 2008 Series D $30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Celleration is funded by 1 investors. HMA Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
HMA Capital Partners Series D